Data Registry of Auto Immune Hemolytic Anemia (DRAIHA)
The DRAIHA Study: Data Registry of AutoImmune Hemolytic Anemia, to Improve Diagnostic Testing for the Development of Personalized Treatment Protocols in AIHA Patients
Sponsor: Amsterdam University Medical Center
Listed as NCT04024202, this observational or N/A phase trial focuses on Autoimmune Hemolytic Anemia and remains ongoing. Sponsored by Amsterdam University Medical Center, it has been updated 11 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Jan 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
-
Mar 2022 — Feb 2024 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Jan 2022 — Mar 2022 [monthly]
Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2019 — Nov 2020 [monthly]
Recruiting
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam University Medical Center
- Erasmus Medical Center
- Haga Hospital
- Isala
- Jeroen Bosch Ziekenhuis
- Leiden University Medical Center
- Maastricht University Medical Center
- Onze Lieve Vrouwe Gasthuis
- Prothya Biosolutions
- Radboud University Medical Center
- Sanquin Research & Blood Bank Divisions
- Spaarne Gasthuis
- St. Antonius Hospital
- UMC Utrecht
For direct contact, visit the study record on ClinicalTrials.gov .